Increasing ApoA-I levels by ApoA-I transgenic mice expression inhibited lymphocyte activation, decreased germinal center B cell numbers at length, and ameliorated glomerulonephritis [13]. The gene discussed is APOA1; the disease is glomerulonephritis.